510(k) device
EndoClot
Endoclot Plus Co., Ltd. · Hemostatic Device For Endoscopic Gastrointestinal Use (QAU, Class II) · First FDA decision Jan 29, 2021, newest Jan 29, 2021Gastrointestinal bleeding
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "EndoClot"
MAUDE reports
38
Brand "EndoClot", since 2015
PubMed studies
25
Mentioning "EndoClot"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing EndoClot
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- EndoClot510(k)
K190677 · Decided Jan 29, 2021 · 686 days after receipt
Device type: Hemostatic Device For Endoscopic Gastrointestinal Use (QAU) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "EndoClot", any status and sponsor, newest update first.
- Hemostatic Powder Following Injection Therapy Versus Conventional Dual Therapy for Endoscopic Hemostasis for Non-variceal Upper Gastrointestinal BleedingPivotal-lookingCompleted
Yonsei UniversityAcademic, hospital or other
NCT02717416 · 226 participants · Start Jul 1, 2017 · Primary completion Apr 26, 2021
Device: Endo-Clot; hemoclip or electrical coagulation · For: Upper Gastrointestinal Bleeding
Sites: Seoul, South Korea
Xijing Hospital of Digestive DiseasesAcademic, hospital or other
NCT01735786 · 164 participants · Start Apr 2010 · Primary completion Feb 2012
Device: EndoClot · For: Endoscopic Hemostasis; Colonic Polyps
Sites: Xi’an, China
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EndoClot", and for the whole product code for context.
This brand
38 reports: 38 malfunction, 0 injury, 0 death
Whole product code QAU
1,141 reports: 957 malfunction, 175 injury, 9 death
Newest reports for this brand
- ENDOCLOT POLYSACCHARIDE HEMOSTATIC SYSTEMMalfunction
MW5184778 · Received Mar 5, 2026 · Event dated Feb 27, 2026
Device type: Hemostatic Device For Endoscopic Gastrointestinal Use (QAU)
Patient problem as coded: Gastrointestinal Hemorrhage
- ENDOCLOTMalfunction
3013155768-2024-00018 · Received Dec 30, 2024
Device type: Hemostatic Device For Endoscopic Gastrointestinal Use (QAU)
Device problem as coded: Complete Blockage
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ENDOCLOTMalfunction
3013155768-2024-00017 · Received Dec 30, 2024
Device type: Compressor, Air, Portable (BTI)
Device problem as coded: Component Missing
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "EndoClot"[tiab]. The summary above synthesizes these.
- Advancements in hemostatic strategies for managing upper gastrointestinal bleeding: A comprehensive review.
Lee AY, Cho JY · World J Gastroenterol · 2024Editorial
- Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review.
Gralnek IM, Bhandari P, Alkandari A, et al. · Endoscopy · 2025Systematic Review
- Novel Therapeutic Strategies in the Management of Non-Variceal Upper Gastrointestinal Bleeding.
Garber A, Jang S · Clin Endosc · 2016Review
- Hemostatic powder application for control of acute upper gastrointestinal bleeding in patients with gastric malignancy.
Kim YJ, Park JC, Kim EH, et al. · Endosc Int Open · 2018
- EndoClot®SIS Polysaccharide Injection as a Submucosal Fluid Cushion for Endoscopic Mucosal Therapies: Results of Ex Vivo and In Vivo Studies.
Dai MS, Hu KW, Wu W, et al. · Dig Dis Sci · 2019Research Support, Non-U.S. Gov't
- EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding: Results of a Prospective Multicenter Observational Pilot Study.
Prei JC, Barmeyer C, Bürgel N, et al. · J Clin Gastroenterol · 2016Multicenter Study, Observational Study
- Multicenter analysis of endoclot as hemostatic powder in different endoscopic settings of the upper gastrointestinal tract.
Hagel AF, Raithel M, Hempen P, et al. · J Physiol Pharmacol · 2020Multicenter Study
- Endoscopic hemostasis state of the art - Nonvariceal bleeding.
Goelder SK, Brueckner J, Messmann H · World J Gastrointest Endosc · 2016Review
- Role of hemostatic powders in the management of lower gastrointestinal bleeding: A review.
Mourad FH, Leong RW · J Gastroenterol Hepatol · 2018Review
- Hemostatic Powders in Non-Variceal Upper Gastrointestinal Bleeding: The Open Questions.
Paoluzi OA, Troncone E, De Cristofaro E, et al. · Medicina (Kaunas) · 2023Review
- Hemostatic powders for gastrointestinal bleeding: a review of old, new, and emerging agents in a rapidly advancing field.
Jiang SX, Chahal D, Ali-Mohamad N, et al. · Endosc Int Open · 2022Review
- Polysaccharide hemostatic system for hemostasis management in colorectal endoscopic mucosal resection.
Huang R, Pan Y, Hui N, et al. · Dig Endosc · 2014
Other devices of this type
Also filed under product code QAU.
- Hemospray Endoscopic Hemostat (HEMO-[X])Wilson-Cook Medical, Inc. · De Novo 2026
- PuraStat3-D Matrix Europe SAS · 510(k) 2026
- NexpowderNextbiomedical Co., Ltd. · 510(k) 2024
- PuraStat GI3-D Matrix, Inc. · 510(k) 2026
- Resolv Endoscopic Hemostat SystemHemostasis, LLC · 510(k) 2024
- PuraStat3-D Matrix, Inc. · 510(k) 2023
- PuraStat-GI3-D Matrix, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.